Earnings History Data for OptimizeRx Corporation (OPRX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

OptimizeRx Corporation

OptimizeRx Corporation provides consumer and physician platforms to help patients better afford and comply with their medicines and healthcare products. It offers pharmaceutical and healthcare companies effective ways to expand patient awareness, access and adherence to their brands. The Company offers marketing and advertising solutions by connecting patients, physicians, and pharmaceutical manufacturers through its consumer Websites. OptimizeRx Corporation is based in Rochester, Michigan.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
06-11-2023	PM		OPRX	OptimizeRx Corporation	138.26	-0.10	-0.19	-0.16	OptimizeRx beats Q3 top and bottom line estimates; initiates FY24 and updates FY23 outlook [11/6/2023 7:10 AM]	9.82	1.33 (15.67%)	10.85	2.36 (27.80%)	6.92 - 22.77	510,253	170,000	33,822
OptimizeRx beats Q3 top and bottom line estimates; initiates FY24 and updates FY23 outlook [11/6/2023 7:10 AM] OptimizeRx jumps after guidance raise [11/6/2023 11:01 AM]
14-08-2023	AH		OPRX	OptimizeRx Corporation	216.49	-0.21	-0.28	-0.18	OptimizeRx Non-GAAP EPS of -$0.01 beats by $0.01, revenue of $13.82M misses by $0.99M [8/14/2023 4:02 PM]	9.08	-3.49 (-27.76%)	9.11	-3.46 (-27.53%)	8.70 - 22.77	561,764	90,000	12,388
OptimizeRx Non-GAAP EPS of -$0.01 beats by $0.01, revenue of $13.82M misses by $0.99M [8/14/2023 4:02 PM]
10-05-2023	AH	4:00 PM ET (May 10)	OPRX	OptimizeRx Corporation	248.64	-0.34	-0.32	-0.18	OptimizeRx Non-GAAP EPS of -$0.09 misses by $0.01, revenue of $13M beats by $0.64M [5/10/2023 4:07 PM]	13.52	-0.76 (-5.32%)	14.28	0.0 (0.00%)	12.20 - 30.82	130,254	90,000	687
OptimizeRx Non-GAAP EPS of -$0.09 misses by $0.01, revenue of $13M beats by $0.64M [5/10/2023 4:07 PM]
08-03-2023	AH	4:00 PM ET (Mar 8)	OPRX	OptimizeRx Corporation	299.66	0.01	0.00	0.03	OptimizeRx Q4 results mixed, co sees FY 2023 Y/Y revenue growth below consensus [3/8/2023 4:04 PM]	14.36	-1.88 (-11.58%)	13.77	-2.47 (-15.21%)	13.33 - 43.28	1,090,310	250,000	7,234
OptimizeRx Q4 results mixed, co sees FY 2023 Y/Y revenue growth below consensus [3/8/2023 4:04 PM] OptimizeRx Q4 top line miss, lackluster 2023 revenue guidance drives shares down 19% [3/8/2023 5:20 PM] OptimizeRx bags contract with Hub services company for better patient access [3/9/2023 8:10 AM]
08-11-2022	AH	4:05 PM ET (Nov 8)	OPRX	OptimizeRx Corporation	254.85	-0.16	-0.18	0.00	OptimizeRx Non-GAAP EPS of $0.07 beats by $0.03, revenue of $15.1M beats by $0.08M [11/8/2022 4:38 PM]	17.82	3.30 (22.73%)	14.52	0.0 (0.00%)	13.33 - 93.67	572,708	160,000	2,541
OptimizeRx Non-GAAP EPS of $0.07 beats by $0.03, revenue of $15.1M beats by $0.08M [11/8/2022 4:38 PM] OptimizeRx Reports Third Quarter 2022 Financial Results [Nov-08-22 04:01PM] OptimizeRx Corp. (OPRX) Tops Q3 Earnings Estimates [Nov-08-22 05:35PM]
09-08-2022	AH	4:00 PM ET (Aug 9)	OPRX	OptimizeRx Corporation	373.03	-0.18	-0.09	0.02	OptimizeRx Q2 Non-GAAP EPS, revenue misses, FY22 guidance below consensus [8/9/2022 4:08 PM]	15.71	-6.54 (-29.39%)	15.00	-7.25 (-32.58%)	13.80 - 99.18	1,522,224	220,000	23,790
OptimizeRx Q2 Non-GAAP EPS, revenue misses, FY22 guidance below consensus [8/9/2022 4:08 PM] OptimizeRx stock sinks 26% on Q2 miss, while FY22 outlook cut on life sciences sector woes [8/10/2022 9:27 AM]
04-05-2022	AH	4:00 PM ET (May 4)	OPRX	OptimizeRx	510.00	-0.18	0.02	0.00	OptimizeRx Non-GAAP EPS of -$0.01 in-line, revenue of $13.73M beats by $0.18M [5/4/2022 4:44 PM]	28.02	-1.95 (-6.51%)	29.50	-0.47 (-1.57%)	26.88 - 99.18	193,176	250,000	8,100
OptimizeRx Non-GAAP EPS of -$0.01 in-line, revenue of $13.73M beats by $0.18M [5/4/2022 4:44 PM] OptimizeRx Reports First Quarter 2022 Financial Results, Revenue Up 22%, Successfully Completes EvinceMed Acquisition [May-04-22 04:01PM] OptimizeRx Corp. (OPRX) Reports Q1 Loss, Lags Revenue Estimates [May-04-22 05:55PM]
24-02-2022	AH	4:05 PM ET (Feb 24)	OPRX	OptimizeRx Corporation	740.10	0.03	0.09	0.11	OptimizeRx Non-GAAP EPS of $0.22 beats by $0.18, revenue of $20.3M beats by $5.5M [2/24/2022 4:49 PM]	45.54	2.57 (5.98%)	43.00	0.03 (0.07%)	37.38 - 99.18	349,892	220,000	1,294
OptimizeRx Non-GAAP EPS of $0.22 beats by $0.18, revenue of $20.3M beats by $5.5M [2/24/2022 4:49 PM] OptimizeRx Reports Fourth Quarter and Full Year 2021 Financial Results, Revenue Increased 42%, Demand from Large Pharma Gains Momentum [Feb-24-22 04:01PM] OptimizeRx Corp. (OPRX) Q4 Earnings and Revenues Beat Estimates [Feb-24-22 05:30PM] OptimizeRx Corporation (OPRX) Q4 2021 Earnings Call Transcript [Feb-25-22 08:01AM]
09-11-2021	AH	4:00 PM ET (Nov 9)	OPRX	OptimizeRx Corporation	1,710	N/A	0.08	-0.01	OptimizeRx EPS misses by $0.04, beats on revenue [11/9/2021 4:17 PM]	85.83	-0.01 (-0.01%)	85.84	0.0 (0.00%)	20.90 - 99.18	354,575	180,000	11,389
OptimizeRx EPS misses by $0.04, beats on revenue [11/9/2021 4:17 PM] OptimizeRx Reports Third Quarter 2021 Financial Results, Revenue Increased 53% in Continued Scale Up for Accelerated Growth [Nov-09-21 04:05PM] OptimizeRx Corp. (OPRX) Misses Q3 Earnings Estimates [Nov-09-21 07:25PM] OPTIMIZERX CORP (OPRX) Q3 2021 Earnings Call Transcript [Nov-10-21 05:32AM] 2 Small Caps That Are Soaring in 2021 [Nov-10-21 06:53AM]
04-08-2021	AH	4:00 PM ET (Aug 4)	OPRX	OptimizeRx Corporation	962.68	0.02	0.02	-0.07	OptimizeRx EPS beats by $0.03, beats on revenue [8/4/2021 4:39 PM]	67.73	10.26 (17.85%)	60.00	2.53 (4.40%)	15.03 - 68.39	480,251	130,000	310
OptimizeRx EPS beats by $0.03, beats on revenue [8/4/2021 4:39 PM] OptimizeRx Reports Second Quarter 2021 Financial Results, Revenue Up 55% as Leading Pharma Brands Aggressively Seek Improved ROI Through Technology Adoption [Aug-04-21 04:01PM] OptimizeRx Corp. (OPRX) Surpasses Q2 Earnings and Revenue Estimates [Aug-04-21 06:35PM]
06-05-2021	AH	4:00 PM ET (May 6)	OPRX	OptimizeRx Corporation	835.12	-0.01	-0.03	-0.15	OptimizeRx EPS beats by $0.03, beats on revenue [5/6/2021 4:03 PM]	52.38	4.43 (9.24%)	52.38	0.0 (0.00%)	9.21 - 63.98	455,271	140,000	609
OptimizeRx EPS beats by $0.03, beats on revenue [5/6/2021 4:03 PM] OptimizeRx Corp. to Host Earnings Call [May-06-21 02:45PM] OptimizeRx Reports First Quarter 2021 Financial Results, Revenue Up 48% on Rising Enterprise Adoption of Digital Health [May-06-21 04:01PM] OptimizeRx Corp. (OPRX) Q1 Earnings and Revenues Beat Estimates [May-06-21 06:25PM] OPTIMIZERX CORP (OPRX) Q1 2021 Earnings Call Transcript [May-07-21 01:31AM]
24-02-2021	AH	4:00 PM ET (Feb 24)	OPRX	OptimizeRx Corporation	962.52	0.11	0.09	-0.10	OptimizeRx EPS beats by $0.01, beats on revenue [2/24/2021 4:06 PM]	56.20	-1.32 (-2.30%)	61.00	3.47 (6.03%)	6.50 - 63.98	380,637	374,860	4,596
OptimizeRx EPS beats by $0.01, beats on revenue [2/24/2021 4:06 PM] 3 Top Healthcare Stocks to Buy in 2021 [Feb-25-21 06:00AM] OptimizeRx Reports Q4 2020 Revenue Up 123% to Record $16.4 Million, Driving Net Income of $1.4 Million or $0.08 Per Share [Feb-24-21 04:01PM] OptimizeRx Corp. to Host Earnings Call [Feb-24-21 02:30PM]
09-11-2020	AH	4:00 PM ET (Nov 9)	OPRX	OptimizeRx Corporation	325.23	-0.01	-0.02	-0.11	OptimizeRx EPS beats by $0.03, beats on revenue [11/9/2020 4:03 PM]	22.81	1.61 (7.59%)	22.20	1.00 (4.72%)	6.50 - 23.50	352,328	78,925	2,872

05-08-2020	AH	4:00 PM ET (Aug 5)	OPRX	OptimizeRx Corporation	207.25	-0.07	-0.09	0.03	OptimizeRx EPS beats by $0.05, beats on revenue [8/5/2020 4:04 PM]	17.22	1.74 (11.24%)	16.28	0.80 (5.17%)	6.50 - 17.29	185,358	86,168	215